Researchers from University of Arizona present a new therapeutic target to shield nerve cells from the damage of ALS.
Researchers at the University of Bayreuth and Forschungszentrum Jülich have demonstrated that specific light-sensitive ...
The expanding interest in small bioactive peptides has brought renewed attention to glycyl-L-histidyl-L-lysine bound to ...
Genetically engineered CAR T cells expressing artificial receptor proteins are increasingly used in the clinic to boost the ...
A new study reveals experimental drug XL20 crosses the blood-brain barrier to stop toxic TDP-43 clumping in ALS.
Unlike traditional proteins, its short structure allows it to act as an epigenetic modulator, potentially influencing gene ...
Permeasis Therapeutics (“Permeasis”), a biotechnology company developing intracellular biologics enabled by its proprietary Membrane Translocation Domain (MTD) platform announced the publication of ...
Genetically engineered CAR T cells expressing artificial receptor proteins are increasingly used in the clinic to boost the ...
Cucumber peel color can decide whether a fruit looks fresh, desirable, and worth buying. In many markets, especially in ...
Ancient evidence suggests a new twist in how we all got here.
Genetically engineered CAR T cells expressing artificial receptor proteins are increasingly used in the clinic to boost the immune system's response ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results